A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
Clinical trial NCT02941042 · COMPLETED
Trial details
- NCT number
- NCT02941042
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-10
- Primary completion
- 2017-09-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.